ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

Overview of attention for article published in BMC Cancer, October 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 1 blog post.

A study from the Mayo Clinic investigates the clinical role of ERbeta1 in breast cancer since previous data has been conflicting.

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.